官方服务：
资源简介：
Novel estrogen and tamoxifen induced genes
应用场景：
创建时间：
2003-07-16
相关数据集
T47D_MTVL treatment with JAK/STAT inhibitor AG490 with/without R5020
Gene expression of the breast cancer cell line T47D-MTVL induced by progestin R5020, in the absense or presence of the JAK/STAT signaling pathway inhibitor AG490. Keywords: Gene expression - T47D-MTVL
NIAID Data Ecosystem50
Fluvastatin-induced differential global gene expression in human metastatic MDA-MB-231 breast cancer cells
The current study analyzed the altered expression profiles of genes that are responsible for fluvastatin-induced breast cancer cell death in MDA-MB-231 cells (ER-ve basal breast cancer cells). Some of
NIAID Data Ecosystem30
DataSheet1_Preliminary Pharmacogenomic-Based Predictive Models of Tamoxifen Response in Hormone-dependent Chilean Breast Cancer Patients.pdf
Tamoxifen (TAM), a selective oestrogen receptor modulator, is one of the most used treatments in oestrogen receptor-positive (ER+) early and metastatic breast cancer (BC) patients. The response to TAM
NIAID Data Ecosystem30
Additional file 2 of Comprehensive pharmacogenomic characterization of gastric cancer
Additional file 2: Table S2. Clinical annotations of 131 gastric cancers used in the drug screening and/or genomic characterization.
Figshare2020-02-19 更新20
